Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis
CONCLUSION: SGLT-2 inhibitors and GLP-1 agonists were shown to be beneficial for stroke prevention in patients with type 2 diabetes mellitus.PMID:38273787 | DOI:10.4093/dmj.2022.0421
Source: Diabetes and Metabolism Journal - Category: Endocrinology Authors: Ji Soo Kim Gyeongsil Lee Kyung-Il Park Seung-Won Oh Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Sodium | Stroke